Home » Topics » Regulatory

Regulatory
RSS

Allergan's therapy for allergic conjunctivitis approved for U.S. marketing

Dec. 27, 1999

Organogenesis seeks FDA approval of Apligraf for diabetic foot ulcers

Dec. 23, 1999

New use for sPLA2 inhibitor claimed by Lilly: LY-315920 for IBS

Dec. 23, 1999

FDA is first agency worldwide to approve new fluoroquinolone for marketing

Dec. 22, 1999

Dexmedetomidine receives FDA marketing approval

Dec. 22, 1999

FDA approves topical treatment for nail fungus

Dec. 21, 1999

Schwarz sells intranasal scopolamine rights to Nastech

Dec. 21, 1999

Swiss regulatory authorities grant Visudyne Therapy its first approval

Dec. 20, 1999

Seretide MDI submitted for European marketing approval

Dec. 17, 1999

Novartis files NDA for extended-release formulation of fluvastatin

Dec. 16, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...